Goldman Sachs analyst Bonnie Herzog lowered the firm's price target on Clorox to $83 from $94 and keeps a Sell rating on the shares. Clorox reported a slight EPS beat for Q3 but issued weaker FY26 guidance and a complex outlook citing oil and gas-driven cost pressures, soft consumer and scanner trends, incremental headwinds from Middle East conflict, ERP transition impacts, and integration of the Purell acquisition, ultimately leading to a disappointing overall update, the analyst tells investors in a research note.
